Vaccines, Blood & Biologics
Complete List of Donor Screening Assays for Infectious Agents and HIV Diagnostic Assays
Return to the Infectious Disease Tests page
Antibody to Hepatitis B Surface Antigen (HBsAg Assay)
|
Tradename(s) |
Format |
Sample |
Use |
Manufacturer |
Approval Date |
|---|---|---|---|---|---|
| EIA | Serum / Plasma / Cadaveric Serum | Donor Screen & Conf Kit | Abbott Laboratories Abbott Park, IL US License 0043 |
4/1/1985 | |
| EIA | Serum / Plasma / Cadaveric Serum | Donor Screen & Conf Kit | Bio-Rad Laboratories Redmond, WA US License 1109 |
1/23/2003 | |
|
ORTHO Antibody to HBsAg ELISA Test System 3 |
EIA | Serum / Plasma | Donor Screen / Diagnosis & Conf Kit | Ortho-Clinical Diagnostics, Inc Raritan, NJ US License 1236 |
4/23/2003 |
| Chemiluminescent Immunoassay (ChLIA) | Serum/Plasma | Donor screening test to detect HBsAg. Also for use in testing blood and plasma to screen organ donors when specimens are obtained while the donor's heart is still beating, and intesting blood specimens to screen cadaveric (non-heart-beating) donors. | Abbott Laboratories Abbott Park, IL US License 0043 |
7/18/2006 |
Anti-HIV-1 Oral Specimen Collection Device
|
Tradename(s) |
Format |
Sample |
Use |
Manufacturer |
Approval Date |
|---|---|---|---|---|---|
|
OraSure HIV-1 Oral Specimen Collection Device |
Oral Specimen Collection Device | Oral Fluid | For Use with HIV diagnostic assays that have been approved for use with this device. | OraSure Technologies Bethlehem, PA |
12/23/1994 |
Anti-HIV-1 Testing Service
|
Tradename(s) |
Format |
Sample |
Use |
Manufacturer |
Approval Date |
|---|---|---|---|---|---|
| Dried Blood Spot Collection Device | Dried Blood Spot | Diagnostic | Home Access Health Corp Hoffman Estates, IL |
7/22/1996 |
Hepatitis B Surface Antigen (Anti-HBs Assay)
|
Tradename(s) |
Format |
Sample |
Use |
Manufacturer |
Approval Date |
|---|---|---|---|---|---|
|
Ausab EIA |
EIA | Serum / Plasma | Anti-HBs | Abbott Laboratories Abbott Park, IL US License 0043 |
11/18/1982 |
Hepatitis B Virus Core Antigen (Anti-HBc Assay)
|
Tradename(s) |
Format |
Sample |
Use |
Manufacturer |
Approval Date |
|---|---|---|---|---|---|
|
CORZYME |
EIA | Serum / Plasma | Donor Screen | Abbott Laboratories Abbott Park, IL US License 0043 |
3/19/1991 |
|
Ortho HBc ELISA Test System |
EIA | Serum / Plasma | Donor Screen | Ortho-Clinical Diagnostics, Inc Raritan, NJ US License 1236 |
4/18/1991 |
| Chemiluminescent Immunoassay (ChLIA) | Serum / Plasma | Donor Screen | Abbott Laboratories Abbott Park, IL US License 0043 |
10/13/2005 |
Hepatitis C Virus Encoded Antigen (Anti-HCV Assay)
|
Tradename(s) |
Format |
Sample |
Use |
Manufacturer |
Approval Date |
|---|---|---|---|---|---|
| EIA | Serum / Plasma / Cadaveric Serum | Donor Screen | Abbott Laboratories Abbott Park, IL US License 0043 |
5/6/1992 | |
|
Ortho HCV Version 3.0 ELISA Test System |
EIA | Serum / Plasma | Donor Screen | Ortho-Clinical Diagnostics, Inc Raritan, NJ US License 1236 |
5/20/1996 |
| SIA | Serum / Plasma | Donor Supplemental | Chiron Corp Emeryville, CA US License 1106 |
2/11/1999 | |
| Chemiluminescent Immunoassay (ChLIA) | Serum / Plasma | Donor screening test for the qualitative detection of antibodies to hepatitis C virus (anti-HCV) in human serum and plasma specimens. Also intended for use in testing blood and plasma to screen organ donors when specimens are obtained while the donor’s heart is still beating, and in testing blood specimens to screen cadaveric (non-heart-beating) donors. | Abbott Laboratories Abbott Park, IL US License 0043 |
7/11/2007 |
Nucleic Acid Testing
|
Tradename(s) |
Format |
Sample |
Use |
Manufacturer |
Approval Date |
|---|---|---|---|---|---|
| PCR | Plasma | Prognosis / Patient Management HIV-1 Viral Load Assay |
Roche Molecular Systems, Inc Pleasanton, CA |
3/2/1999 | |
| NASBA | Plasma | Prognosis / Patient Management HIV-1 Viral Load Assay |
bioMerieux, Inc Durham, NC |
11/19/2001 | |
| PCR | Plasma | Donor Screen Expanded Indications For Use: Source Plasma donors, other living donors, and organ donors |
Roche Molecular Systems, Inc Pleasanton, CA US License 1636 |
12/20/2002 | |
| HIV-1/HCV Nucleic Acid Test (TMA) | Plasma | Donor Screen Expanded Indications For Use: Source Plasma donors, living organ donors and cadaveric samples |
Gen-Probe San Diego, CA US License 1592 |
6/4/2004 | |
|
Trugene HIV-1 Genotyping Kit and Open Gene DNA Sequencing System |
HIV-1 Genotyping | Plasma | Patient Monitoring | Siemens Medical Solutions Diagnostics Berkeley, CA |
4/24/2002 |
| PCR | Plasma | Donor Screen | National Genetics Institute Los Angeles, CA 92121 |
9/18/2001 | |
| PCR | Plasma | Donor Screen | National Genetics Institute Los Angeles, CA 92121 |
9/18/2001 | |
|
ViroSeq HIV-1 Genotyping System with the 3700 Genetic Analyzer |
HIV-1 Genotyping | Plasma | Patient Monitoring | Celera Diagnostics Alameda, CA |
6/11/2003 |
| Signal amplification nucleic acid probe | Plasma | Patient Monitoring |
Siemens Medical Solutions Diagnostics Berkeley, CA |
9/11/2002 | |
| PCR | Plasma | Donor Screen Expanded Indications For Use: Source Plasma donors, other living donors, and organ donors |
Roche Molecular Systems, Inc Pleasanton, CA US License 1636 |
12/3/2002 | |
| PCR | Plasma | Donor Screen Indications For Use: Source Plasma donors, other living donors, and organ donors |
Roche Molecular Systems, Inc Pleasanton, CA US License 1636 |
4/21/2005 | |
| Nucleic Acid Test (TMA) | Plasma | Qualitative detection of West Nile Virus (WNV) RNA from volunteer donors of whole blood and blood components, screen organ donors when obtained while donor's heart is still beating, and test blood specimens to screen cadaveric donors | Gen-Probe San Diego, CA US License 1592 |
12/1/2005 | |
| APTIMA HIV-1 RNA Qualitative Assay | HIV-1 and HCV/Nucleic Acid Pooled Testing/Synthetic | Plasma | For use as an aid in diagnosis of HIV-1 infection, including acute or primary infection. | Gen-Probe, Inc US License 1592 |
10/4/2006 |
| Nucleic Acid Test (TMA) | Plasma and Serum | Qualitative detection of human immunodeficiency virus type 1 (HIV-1) RNA and hepatitis C virus (HCV) RNA from volunteer donors of whole blood and blood components, screen organ donors when obtained while donor's heart is still beating, and test blood specimens to screen cadaveric donors. 8/12/2008 Additional Indication: Revision of Intended Use to include an HBV screening claim for individual samples and pooled samples of up to 16 individual donations. An Intended Use to include testing of pools of up to 16 donations from donors of Hematopoietic Progenitor Cells (HPCs) or Donor Lymphocytes for Infusion (DLI). |
Gen-Probe San Diego, CA US License 1592 |
10/3/2006 | |
|
Hepatitis C Virus (HCV) Reverse Transcription (RT) Polymerase Chain Reaction (PCR) assay |
PCR | Plasma | Qualitative detection of HCV ribonucleic acid (RNA) in pools of human Source Plasma comprised of equal aliquots of not more than 512 individual plasma samples. | BioLife Plasma Services, L.P. Deerfield, IL US License 1640 |
2/9/2007 |
| PCR | Plasma | Qualitative detection of HIV-1 ribonucleic acid (RNA) in pools of human Source Plasma comprised of equal aliquots of not more than 512 individual plasma samples. | BioLife Plasma Services, L.P. Deerfield, IL US License 1640 |
1/31/2007 | |
| PCR | Plasma | Quantitation of Human Immunodeficiency Virus type 1 (HIV- 1) on the automated m2000 System. Not intended to be used as a donor screening test. | ABBOTT Molecular, Inc Des Plaines, IL |
5/11/2007 | |
| PCR | Plasma | Quantitation of Human Immunodeficiency Virus Type 1 (HIV-1) nucleic acid. Not intended to be used as a donor screening test. | Roche Molecular Systems, Inc Pleasanton, CA |
5/11/2007 | |
| PCR | Plasma | For the qualitative detection of West Nile Virus (WNV) RNA in plasma specimens from individual human donors, donors of whole blood and blood components, and other living donors. Also intended for use in testing plasma specimens to screen organ donors when specimens are obtained while the donor’s heart is still beating. | Roche Molecular Systems, Inc Pleasanton, CA US License 1636 |
8/28/2007 |
Human Immunodeficiency Virus Type 1 (Anti-HIV-1 Assay)
|
Tradename(s) |
Format |
Sample |
Use |
Manufacturer |
Approval Date |
|---|---|---|---|---|---|
| EIA | Serum / Plasma | Donor Screen | Bio-Rad Laboratories Redmond, WA US License 1109 |
6/29/1998 | |
|
Cambridge Biotech HIV-1 Western Blot Kit |
WB | Serum / Plasma | Donor Supplemental | Calypte Biomedical Corp Berkeley, CA US License 1207 |
1/3/1991 |
|
GS HIV-1 Western Blot |
WB | Serum / Plasma | Donor Supplemental | Bio-Rad Laboratories Redmond, WA US License 1109 |
11/13/1998 |
|
Fluorognost HIV-1 IFA |
IFA | Serum / Plasma | Donor Supplemental | Waldheim Pharmazeutika GmbH Vienna, Austria US License 1150 |
2/5/1992 |
|
HIVAB HIV-1 EIA |
EIA | Dried Blood Spot | Diagnostic | Abbott Laboratories | 4/22/1992 |
|
HIV-1 Urine EIA |
EIA | Urine Screen | Diagnostic | Calypte Biomedical Corp | 8/6/1996 |
| EIA | Dried Blood Spot | Diagnostic | Bio-Rad Laboratories Redmond, WA |
6/29/1998 | |
| WB | Urine | Diagnostic Supplemental | Maxim Biomedical, Inc | 5/28/1998 | |
|
GS HIV-1 Western Blot |
WB | Dried Blood Spot | Diagnostic Supplemental | Bio-Rad Laboratories Redmond, WA |
11/13/1998 |
| WB | Oral Fluid | Diagnostic Supplemental | OraSure Technologies Bethlehem, PA |
6/3/1996 | |
|
Fluorognost HIV-1 IFA |
IFA | Dried Blood Spot | Diagnostic Supplemental | Waldheim Pharmazeutika GmbH | 5/14/1996 |
| Rapid Immunoassay | Serum / Plasma | Diagnostic | MedMira Laboratories, Inc Halifax, Nova Scotia Canada B3S 1B3 |
4/16/2003 | |
| Rapid Immunoassay | Serum / Plasma / Whole Blood (venipuncture and fingerstick) |
Diagnostic | Trinity Biotech, plc Bray Co., Wicklow Ireland |
12/23/2003 |
Human Immunodeficiency Virus Types 1 & 2 (Anti-HIV-1/2 Assay)
|
Tradename(s) |
Format |
Sample |
Use |
Manufacturer |
Approval Date |
|---|---|---|---|---|---|
| EIA | Serum / Plasma / Cadaveric Serum | Donor Screen | Abbott Laboratories Abbott Park, IL US License 0043 |
2/14/1992 | |
| EIA | Serum / Plasma / Cadaveric Serum | Donor Screen | Bio-Rad Laboratories Redmond, WA US License 1109 |
8/5/2003 | |
| Rapid Immunoassay | Plasma / Serum | Diagnostic | Bio-Rad Laboratories Redmond, WA |
11/12/2004 | |
| Rapid Immunoassay | Whole Blood, Plasma, Oral Fluid | Diagnostic | OraSure Technologies Bethlehem, PA |
6/22/2004 | |
|
|
Chemiluminescent immunoassay (ChLIA) | Serum / Plasma / Cadaveric Serum | To be used to screen individual human donors, including volunteer donors of Whole Blood and blood components and other living donors, for the presence of anti-HIV-1 Groups M and O and/or anti-HIV-2. The assay is also intended for use in testing blood and plasma specimens to screen organ donors when specimens are obtained while the donor’s heart is still beating, in testing blood specimens to screen cadaveric (non–heart-beating) donors. | Abbott Laboratories | 9/18/2009 |
| Microparticle Chemiluminometric Immunoassay | Plasma/Serum | Diagnostic for qualitative determination of antibodies to the human immunodeficiency virus type 1, including Group O, and/or type 2 in serum or plasma | Siemens Medical Solutions Diagnostics Tarrytown, NY |
5/18/2006 | |
| Rapid Immunoassay | Fingerstick & venous whole blood, serum, plasma | Diagnostic | Chembio Diagnostic Systems, Inc Medford, NY |
5/25/2006 |
Human Immunodeficiency Virus Type 2 (Anti-HIV-2 Assay)
|
Tradename(s) |
Format |
Sample |
Use |
Manufacturer |
Approval Date |
|---|---|---|---|---|---|
|
GS HIV-2 EIA |
EIA | Serum / Plasma | Donor Screen | Bio-Rad Laboratories Redmond, WA US License 1109 |
4/25/1990 |
Human T-Lymphotropic Virus Types I & II (Anti-HTLV-I/II Assay)
|
Tradename(s) |
Format |
Sample |
Use |
Manufacturer |
Approval Date |
|---|---|---|---|---|---|
| EIA | Serum / Plasma | Donor Screen | Abbott Laboratories Abbott Park, IL US License 0043 |
8/15/1997 | |
| ABBOTT PRISM HTLV-I/HTLV-II | Chemiluminescent Immunoassay (ChLIA) | Serum / Plasma | To be used as a screening test for individual human donors, including volunteer donors of whole blood and blood components, and other living donors for the presence of anti-HTLV-I/HTLV-II. It is also intended for use in testing blood and plasma to screen organ donors when specimens are obtained while the donor’s heart is still beating. | Abbott Laboratories Abbott Park, IL US License 0043 |
1/16/2008 |
Trypanosoma cruzi (T. cruzi) (Anti- T. cruzi Assay)
|
Tradename(s) |
Format |
Sample |
Use |
Manufacturer |
Approval Date |
|---|---|---|---|---|---|
| EIA | Serum / Plasma | Donor screening test to detect antibodies to T. cruzi in plasma and serum samples from individual human donors. Also intended for use to screen organ and tissue donors when specimens are obtained while the donor's heart is still beating | Ortho-Clinical Diagnostics, Inc Raritan, NJ US License 1236 |
12/13/2006 |
Return to the Infectious Disease Tests page
Contact Us
Consumer Affairs Branch (CBER)
- (800) 835-4709
- (301) 827-1800
- ocod@fda.hhs.gov
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448

